Epigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence

Mai Fujimoto1, Yasunobu Mano1, Motonobu Anai1

  • 1Mai Fujimoto, Shogo Yamamoto, Hiroyuki Aburatani, Atsushi Kaneda, Genome Science Division, Research Center for Advanced Science and Technology, the University of Tokyo, Tokyo 153-8904, Japan.

Abstract

Insights

Oncogenic Raf induces cellular senescence with altered gene expression and epigenomic changes, similar to Ras-induced senescence. Key factors like Bmp2 upregulation and Smad6 repression contribute to this process.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cellular Senescence

Background:

  • Oncogenic signaling pathways, such as those involving Raf and Ras, are known to induce cellular senescence.
  • Cellular senescence is a state of irreversible cell cycle arrest with significant changes in gene expression and epigenomic landscape.
  • Understanding the specific molecular mechanisms driving oncogene-induced senescence is crucial for cancer research and therapy.

Purpose of the Study:

  • To investigate the epigenomic and gene expression alterations during cellular senescence induced by oncogenic Raf.
  • To compare these alterations with those observed in Ras-induced senescence.

Main Methods:

  • Cellular senescence was induced in mouse embryonic fibroblasts (MEFs) using oncogenic Raf (RafV600E).
  • Genome-wide gene expression analysis was performed using microarray.
  • Epigenomic status, including H3K4me3 and H3K27me3 histone marks, was analyzed using chromatin immunoprecipitation-sequencing (ChIP-seq).
  • Data were compared with previously obtained data for Ras-induced senescence.

Main Results:

  • Raf-induced senescence showed significant overlap in gene expression and epigenomic alterations with Ras-induced senescence, particularly for secreted proteins.
  • Bone morphogenetic protein 2 (Bmp2) was upregulated with H3K4me3 gain and H3K27me3 loss, and its knockdown led to escape from senescence.
  • Smad6, an inhibitor of Bmp2-Smad signaling, was repressed with H3K4me3 loss, and its induction bypassed senescence.
  • While H3K27me3 loss overlapped between Ras and Raf senescence, H3K27me3 gain showed rare overlap, indicating partly distinct epigenetic regulation.

Conclusions:

  • Oncogenic Raf induces cellular senescence through specific epigenomic and gene expression changes.
  • Bmp2 upregulation and Smad6 repression are key contributors to Raf-induced senescence, mirroring findings in Ras-induced senescence.
  • Despite similarities, distinct epigenetic alterations, particularly regarding H3K27me3 gain, highlight pathway-specific regulatory nuances.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K